The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...

Myasthenia gravis (MG) in children and adolescents to age 18 -- juvenile MG -- includes clinically significant developmental issues like puberty that are not present in adult disease. Despite this, ...

HOUSTON - The U.S. Food and Drug Administration has agreed to Moleculin Biotech, Inc.’s (NASDAQ:MBRX) proposal for a single pediatric approval study of its cancer drug Annamycin in combination ...

INCHEON, South Korea, June 16, 2025 /PRNewswire/ -- Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA ... The additional presentation is approved for the treatment of ...

U.S. drug deaths dropped by roughly 40% last year among people under the age of 35. It's a welcome pivot for families and communities devastated by fentanyl.

A chart review of patients affected by sarcoma admitted between March 2015 and August 2018 at the Bambino Gesù Children Hospital, one of the main pediatric oncology centers in Italy, was done. All ...

Introduction: Pediatric drug-resistant epilepsy (DRE) is defined as epilepsy that is not controlled by two or more appropriately chosen and dosed anti-seizure medications (ASMs). When alternative ...

Keep reading for specific information about the dosage of Wegovy, including its strengths and how to use the medication. For a comprehensive look at Wegovy, see this in-depth Wegovy article.

An off-label prescription drug has been shown to help children with autism gain the ability to speak. Leucovorin is used for cancer patients, but doctors are pushing for its approval for autism.